Brigitte Ute Lindsay - 13 Feb 2026 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Accounting Officer
Signature
/s/ Brigitte Lindsay
Issuer symbol
CRDF
Transactions as of
13 Feb 2026
Net transactions value
$0
Form type
4
Filing time
18 Feb 2026, 16:02:04 UTC
Previous filing
09 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lindsay Brigitte Ute Chief Accounting Officer 11055 FLINTKOTE AVENUE, SAN DIEGO /s/ Brigitte Lindsay 18 Feb 2026 0002110286

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +200,000 +24% $0.000000 1,025,334 13 Feb 2026 Common Stock 200,000 $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 vest on February 13, 2027 and 4,166 vest monthly for 36 months thereafter.